Ausgabe 6/2022
Inhalt (20 Artikel)
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings
Nourhan Shalaby, Veronica Phyllis Dubois, John Ronald
Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
Kui Cao, Mingdong Liu, Keru Ma, Xiangyu Jiang, Jianqun Ma, Jinhong Zhu
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
Jun-Nan Guo, Du Chen, Shen-Hui Deng, Jia-Rong Huang, Jin-Xuan Song, Xiang-Yu Li, Bin-Bin Cui, Yan-Long Liu
Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects
Cheng Pan, Yukio Fujiwara, Hasita Horlad, Toyohisa Iriki, Daisuke Shiraishi, Yoshihiro Komohara
First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis
Mingfeng He, Taihao Zheng, Xiaoyue Zhang, Yuan Peng, Xuan Jiang, Yusheng Huang, Benxu Tan, Zhenzhou Yang
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, Masashi Arita, Ko Sato, Miyuki Sato, Yuki Sekiya, Yuko Abe, Toshiya Fujisaki, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Yu Saida, Satoshi Hokari, Nobumasa Aoki, Masachika Hayashi, Yasuyoshi Ohshima, Toshiyuki Koya, Toshiaki Kikuchi
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes
Semjon Sidorov, Lara Fux, Katja Steiner, Samyo Bounlom, Sabrina Traxel, Tarik Azzi, Arbeneshe Berisha, Christoph Berger, Michele Bernasconi, Felix K. Niggli, Yvonne Perner, Sugeshnee Pather, Werner Kempf, David Nadal, Simone Bürgler
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
Jin-Ji Yang, Cheng Huang, Yun Fan, Hongming Pan, Jifeng Feng, Liyan Jiang, Xing-Ya Li, Xiao-Qing Liu, Jian-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, Rui Ma, Jie Wang, Yina Wang, Yan-Hui Liu, Dong-Mei Lin, Tao Wang, Wei Shi, Jianjun Zou, Yi-Long Wu
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
Defeng Jiao, Xiaohu Zheng, Xianghui Du, Dong Wang, Ziming Hu, Rui Sun, Zhigang Tian, Binqing Fu, Haiming Wei
Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
Toru Kiguchi, Masaki Yamaguchi, Naoki Takezako, Shuichi Miyawaki, Koichi Masui, Yuichiro Ihara, Masao Hirota, Naoko Shimofurutani, Tomoki Naoe
Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
Meng Qin, Junzo Hamanishi, Masayo Ukita, Koji Yamanoi, Shiro Takamatsu, Kaoru Abiko, Ryusuke Murakami, Taito Miyamoto, Haruka Suzuki, Akihiko Ueda, Yuko Hosoe, Akihito Horie, Ken Yamaguchi, Masaki Mandai
Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study
Kaili Yang, Lu Han, Shikai Wu, Xiujuan Qu, Qin Li, Chuanhua Zhao, Jing Zhou, Xuan Jin, Yusheng Wang, Dong Yan, Zhiqiang Cheng, Yuwei Hua, Yan Zhang, Yang Ge, Jinghua Sun, Wei Deng, Lin Zhao, Yunbo Zhao
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Mina Hibino, Paige Wright, Ari J. Cohen, Paul T. Thevenot
Clinical determinants of long-term survival in metastatic uveal melanoma
Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Michael Erdmann, Lucie Heinzerling, Bettina Hohberger, Harald Knorr, Ulrike Leiter, Friedegund Meier, Peter Mohr, Farnaz Rahimi, Beatrice Schell, Max Schlaak, Patrick Terheyden, Beatrice Schuler-Thurner, Selma Ugurel, Jochen Utikal, Julio Vera, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt
Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing
Divya Ravirala, Guangsheng Pei, Zhongming Zhao, Xiaoliu Zhang
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer
Mengmeng Sun, Han Zeng, Kaifeng Jin, Zhaopei Liu, Baoying Hu, Chunnan Liu, Sen Yan, Yanze Yu, Runze You, Hongyi Zhang, Yuan Chang, Li Liu, Yu Zhu, Jiejie Xu, Le Xu, Zewei Wang
Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model
Bo Wang, Zhihua He, Hao Yu, Ziwei Ou, Junyu Chen, Meihua Yang, Xinxiang Fan, Tianxin Lin, Jian Huang
Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer
Hui Li, Miaofang Wu, Zhuna Wu, Jinxiao Liang, Lijuan Wang, Xi Yang, Zhongqiu Lin, Jing Li
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J. Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon Luah, Chwee Ming Lim, Nivashini Kaliaperumal, Veonice B. Au, Najwa Binte Said Nasir Talib, Reina Sng, John E. Connolly, Boon Cher Goh, Herbert Schwarz
Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy
V. Conteduca, M. Medri, L. Mazzoni, U. De Giorgi, I. Stanganelli